Micronized acellular dermal matrix as an efficient expansion substrate and delivery vehicle of adipose-derived stem cells for vocal fold regeneration

Laryngoscope

Volumn 122, Issue 8, 2012, Pages 1815-1825

  Liang, Qiang ^a   Liu, Shiyu ^b   Han, Peng ^a   Li, Xiaofeng ^a   Li, Xiaobing ^a   Zhao, Yu ^a   Liang, Yuanyuan ^a   Deng, Zhihong ^a   Jin, Yan ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

extracellular matrix; Mesenchymal stem cells; scaffold; vocal fold scarring

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DESMIN; MYOSIN;

ACELLULAR DERMAL MATRIX; ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; LARYNGOSCOPY; LARYNX INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION; TISSUE REGENERATION; TISSUE STRUCTURE; VOCAL CORD; VOCAL CORD DISORDER; VOCAL CORD TRAUMA; VOCAL FOLD REGENERATION;

ADIPOCYTES; ANIMALS; ATROPHY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CICATRIX; EXTRACELLULAR MATRIX; MEMBRANE GLYCOPROTEINS; RABBITS; REGENERATION; STEM CELL TRANSPLANTATION; TETRAZOLIUM SALTS; THIAZOLES; VOCAL CORDS;

EID: 84864414546     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23330     Document Type: Article

References (43)

1. Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: current concepts and management. Otolaryngol Head Neck Surg 1996; 115: 474-482. (Pubitemid 26378553)
2. Hansen JK, Thibeault SL,. Current understanding and review of the literature: vocal fold scarring. J Voice 2006; 20: 110-120. (Pubitemid 43289093)
3. Gray SD, Titze IR, Alipour F, Hammond TH,. Biomechanical and histologic observations of vocal fold fibrous proteins. Ann Otol Rhinol Laryngol 2000; 109: 77-85. (Pubitemid 30051786)
4. Krischke S, Weigelt S, Hoppe U, et al. Quality of life in dysphonic patients. J Voice 2005; 19: 132-137. (Pubitemid 40342782)
5. Murry T, Medrado R, Hogikyan ND, Aviv JE,. The relationship between ratings of voice quality and quality of life measures. J Voice 2004; 18: 183-192. (Pubitemid 38757545)
6. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN,. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002; 16: 96-104. (Pubitemid 36626574)
7. Hahn MS, Teply BA, Stevens MM, Zeitels SM, Langer R,. Collagen composite hydrogels for vocal fold lamina propria restoration. Biomaterials 2006; 27: 1104-1109. (Pubitemid 41566704)
8. Jia X, Yeo Y, Clifton RJ, et al. Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration. Biomacromolecules 2006; 7: 3336-3344. (Pubitemid 46111788)
9. Xu CC, Chan RW, Tirunagari N,. A biodegradable, acellular xenogeneic scaffold for regeneration of the vocal fold lamina propria. Tissue Eng 2007; 13: 551-566. (Pubitemid 46579881)
10. Kanemaru S, Nakamura T, Omori K, et al. Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol 2003; 112: 915-920. (Pubitemid 37429633)
11. Hertegard S, Cedervall J, Svensson B, et al. Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection. Laryngoscope 2006; 116: 1248-1254. (Pubitemid 44317959)
12. Lee BJ, Wang SG, Lee JC, et al. The prevention of vocal fold scarring using autologous adipose tissue-derived stromal cells. Cells Tissues Organs 2006; 184: 198-204.
13. Chhetri DK, Head C, Revazova E, Hart S, Bhuta S, Berke GS,. Lamina propria replacement therapy with cultured autologous fibroblasts for vocal fold scars. Otolaryngol Head Neck Surg 2004; 131: 864-870. (Pubitemid 39575943)
14. Cedervall J, Ahrlund-Richter L, Svensson B, et al. Injection of embryonic stem cells into scarred rabbit vocal folds enhances healing and improves viscoelasticity: short-term results. Laryngoscope 2007; 117: 2075-2081. (Pubitemid 350059395)
15. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6: 1282-1286.
16. Morandi F, Raffaghello L, Bianchi G, et al. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells 2008; 26: 1275-1287.
17. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147. (Pubitemid 29282067)
18. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295. (Pubitemid 35471185)
19. Wu Y, Chen L, Scott PG, Tredget EE,. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25: 2648-2659. (Pubitemid 47582758)
20. Kang SW, Seo SW, Choi CY, Kim BS,. Porous poly(lactic-co-glycolic acid) microsphere as cell culture substrate and cell transplantation vehicle for adipose tissue engineering. Tissue Eng Part C Methods 2008; 14: 25-34. (Pubitemid 351520455)
21. Yang Y, Rossi FM, Putnins EE,. Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. Biomaterials 2007; 28: 3110-3120. (Pubitemid 46602522)
22. Lee SJ, Lee IW, Lee YM, Lee HB, Khang G,. Macroporous biodegradable natural/synthetic hybrid scaffolds as small intestine submucosa impregnated poly(D,L-lactide-co-glycolide) for tissue-engineered bone. J Biomater Sci Polym Ed 2004; 15: 1003-1017. (Pubitemid 39220358)
23. Qi X, Ye J, Wang Y,. Improved injectability and in vitro degradation of a calcium phosphate cement containing poly(lactide-co-glycolide) microspheres. Acta Biomater 2008; 4: 1837-1845.
24. Badylak SF, Freytes DO, Gilbert TW,. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater 2009; 5: 1-13.
25. Gilbert TW, Sellaro TL, Badylak SF,. Decellularization of tissues and organs. Biomaterials 2006; 27: 3675-3683.
26. Zhang X, Deng Z, Wang H, et al. Expansion and delivery of human fibroblasts on micronized acellular dermal matrix for skin regeneration. Biomaterials 2009; 30: 2666-2674.
27. Wang C, Gong Y, Lin Y, Shen J, Wang DA,. A novel gellan gel-based microcarrier for anchorage-dependent cell delivery. Acta Biomater 2008; 4: 1226-1234.
28. Conconi MT, Nico B, Rebuffat P, et al. Angiogenic response induced by acellular femoral matrix in vivo. J Anat 2005; 207: 79-83. (Pubitemid 41025274)
29. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S,. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 2000; 20: 173-177. (Pubitemid 30209647)
30. Kutty JK, Webb K,. Tissue engineering therapies for the vocal fold lamina propria. Tissue Eng Part B Rev 2009; 15: 249-262.
31. Kurita S, Nagata K, Hirano M,. A comparative study of the layer structure of the vocal fold. In:, Bless DM, Abss JH, eds. Vocal Fold Physiology: Contemporary Research and Clinical Issues. San Diego, CA: College Hill Press; 1983: 3.
32. Desmouliere A, Chaponnier C, and, Gabbiani G,. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005; 13: 7-12. (Pubitemid 40250424)
33. Hinz B,. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007; 127: 526-537.
34. Rousseau B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003; 113: 620-627. (Pubitemid 36406908)
35. Hirano S, Bless DM, Rousseau B, et al. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope 2004; 114: 548-556. (Pubitemid 38391923)
36. Xie JL, Bian HN, Qi SH, et al. Basic fibroblast growth factor (bFGF) alleviates the scar of the rabbit ear model in wound healing. Wound Repair Regen 2008; 16: 576-581. (Pubitemid 352000323)
37. Ohno T, Hirano S, Kanemaru S, et al. Expression of extracellular matrix proteins in the vocal folds and bone marrow derived stromal cells of rats. Eur Arch Otorhinolaryngol 2008; 265: 669-674.
38. van der Veer WM, Bloemen MC, Ulrich MM, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns 2009; 35: 15-29.
39. Zhang Q, Shi S, Liu Y, et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 2009; 183: 7787-7798.
40. Halum SL, Hiatt KK, Naidu M, Sufyan AS, Clapp DW,. Optimization of autologous muscle stem cell survival in the denervated hemilarynx. Laryngoscope 2008; 118: 1308-1312.
41. Thibeault SL, Klemuk SA, Smith ME, Leugers C, Prestwich G,. In vivo comparison of biomimetic approaches for tissue regeneration of the scarred vocal fold. Tissue Eng Part A 2009; 15: 1481-1487.
42. Duflo S, Thibeault SL, Li W, Shu XZ, Prestwich GD,. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng 2006; 12: 2171-2180. (Pubitemid 44734976)
43. Ohno S, Hirano S, Tateya I, et al. Atelocollagen sponge as a stem cell implantation scaffold for the treatment of scarred vocal folds. Ann Otol Rhinol Laryngol 2009; 118: 805-810.